Microcaps to raise CHF 5M co-lead by Helvetica Capital and Zürcher Kantonalbank.
Microcaps, a Zurich (Schlieren), Switzerland-based maunfacturing startup, announced securing a seed funding round of CHF 5M ($5.6M).
The money was raised from investors from Switzerland co-led by Helvetica Capital and Zürcher Kantonalbank and including contributions form the ETH Zurich Foundation, the Lichtsteiner Foundation and a group of Swiss angel investors whose name was not disclosed.
The proceeds will be used to launch the company's first product, a customized microcapsule production unit and associated consumables for sample batch sizes, and grow its team, which will be based at new corporate facilities in Zurich.
Microcaps, founded in 2018 by co-founders Alessandro Ofner and Michael Hagander, developed a proprietary method to manufacture microcapsules in identical sizes that are used in pharmaceuticals, nutrition, cosmetics and other branches of industry.
This means they all have exactly the same effect, with dosage and delivery rate of the active ingredient completely controlled. For drugs, this will allow precision dosing that could result in fewer side effects. In addition, the microcapsules with a controlled size can be produced 1000 times faster than with currently available devices.